focus -WSS

focus

author：knowledge 2025-09-30 16:26:33 - browse：67819

PHILADELPHIA — Novo Nordisk, which has dominated the diabetes and obesity markets with its blockbuster drugs Ozempic and Wegovy, now also wants to be a major player in heart disease.

The landmark Select trial presented over the weekend — which showed Wegovy significantly cut the risk of heart complications — is just one of many efforts by the Danish drugmaker to expand into the cardiovascular space. It’s also developing several treatments specific to heart disease and is acquiring a medication for high blood pressure.

“We have a clear vision of being an established cardiovascular company, just as we see ourselves as leaders in diabetes and obesity,” Martin Lange, Novo’s executive vice president of development, said in an interview here at the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： The painfully weak evidence on taking collagen to treat arthritis

knowledge

WSS

PlayStation controller and acoustic messaging: How the missing Titanic tourist sub works

ThunderShirts, dance parties and anxiety meds can help ease dogs' July Fourth dread

Judge schedules Friday hearing on proposed protective order in Jan. 6 case

Biden praises World Series champion Astros for impact off the field during White House celebration

Michigan man accused of striking an officer during the US Capitol attack is arrested in Florida

3 killed, 8 injured in late

focus

focus

knowledge

Guidelines to prevent youth baseball injuries need more muscle

More regulation could be coming for drug ads

Heart attack and stroke risk calculators need revising

Some in Scotland's Orkney Islands want to return to Norway after 550 years

Virginia high school admissions case could be legal follow

An Ebola outbreak presents a new mystery involving children

New air purifier tech could be key to improving indoor air quality

Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical

George Santos makes 1st court appearance after pleading not guilty to 13 counts

In venture capital firm's success, lessons for turning crisis into profit

focus

Choosing scientific sides in the fight against Alzheimer's

The painfully weak evidence on taking collagen to treat arthritis

1 dead, 9 hurt in July 4th fireworks explosion

Ukraine holds disaster drills amid fears Russia could sabotage nuclear power plant

Chicago flooding is stark reminder of vulnerability of major cities during extreme weather

Ukraine holds disaster drills amid fears Russia could sabotage nuclear power plant

focus

knowledge

focus

focus